Sysmex (OTCMKTS:SSMXY) Releases Earnings Results

Sysmex (OTCMKTS:SSMXY - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.17 earnings per share (EPS) for the quarter, Zacks reports. Sysmex updated its FY 2024 guidance to 0.580-0.580 EPS.

Sysmex Trading Down 1.0 %

OTCMKTS:SSMXY traded down $0.18 during mid-day trading on Friday, hitting $17.90. The company had a trading volume of 58,775 shares, compared to its average volume of 84,987. Sysmex has a fifty-two week low of $14.38 and a fifty-two week high of $28.58. The business's fifty day moving average is $18.74 and its two-hundred day moving average is $19.02. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.42 and a current ratio of 3.19. The firm has a market cap of $11.27 billion, a P/E ratio of 36.91 and a beta of 0.90.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.